Transaction will pad company’s cell analysis franchise.


Roche is taking over innovatis, a provider of automated cell analysis solutions, for €15 million, or $19.56 million. The firm focuses on cell counting, viability testing, and cell function analysis in research as well as bioproduction.

The transaction is expected to be completed within the next few weeks. Innovatis will become a fully-integrated part of Roche Applied Science.

“This acquisition is a further step in our strategy to strengthen our position as a complete solution provider in the cell analysis research market,” says Jürgen Schwiezer, Ph.D., CEO of Roche Diagnostics. “Innovatis’ technology will complement the existing Roche cell analysis portfolio and is synergistic to the xCELLigence technology launched in 2008.”

 








This site uses Akismet to reduce spam. Learn how your comment data is processed.